PET imaging

You have access
PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non–Small Cell Lung Cancer
Jasper Smit, Frank J. Borm, Anna-Larissa N. Niemeijer, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Daniela E. Oprea-Lager, Danielle J. Vugts, Guus A.M.S. van Dongen, Berlinda J. de Wit-van der Veen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen

Journal of Nuclear Medicine May 1, 2022, 63 (5) 686-693; DOI: https://doi.org/10.2967/jnumed.121.262473
You have access
CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of ⁸⁹Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
Michael D. Farwell, Raymond F. Gamache, Hasan Babazada, Matthew D. Hellmann, James J. Harding, Ron Korn, Alessandro Mascioni, William Le, Ian Wilson, Michael S. Gordon, Anna M. Wu, Gary A. Ulaner, Jedd D. Wolchok, Michael A. Postow and Neeta Pandit-Taskar

Journal of Nuclear Medicine May 1, 2022, 63 (5) 720-726; DOI: https://doi.org/10.2967/jnumed.121.262485
You have access
⁸⁹Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted ²²⁷Th-conjugate therapy in mice
Linda N Broer, Daan G Knapen, Frans Valentijn Suurs, Ingrid Moen, Danique Giesen, Stijn J H Waaijer, Baard Indrevoll, Christine Ellingsen, Alexander Kristian, Alan S Cuthbertson, Derk-Jan A de Groot, Patricia E Cole, Elisabeth G.E. de Vries, Urs B Hagemann and Marjolijn N Lub - de Hooge

Journal of Nuclear Medicine April 14, 2022, jnumed.121.263079; DOI: https://doi.org/10.2967/jnumed.121.263079
You have access
¹⁸F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer after Curative-intent Radiation Therapy: A Bicentric Retrospective Study
Harun Ilhan, Markus Kroenke, Alexander Wurzer, Marcus Unterrainer, Matthias Heck, Claus Belka, Karina Knorr, Thomas Langbein, Isabel Rauscher, Nina-Sophie Schmidt-Hegemann, Kilian Schiller, Peter Bartenstein, Hans-Jürgen Wester and Matthias Eiber

Journal of Nuclear Medicine March 10, 2022, jnumed.121.262861; DOI: https://doi.org/10.2967/jnumed.121.262861
You have access
The History of Prostate-Specific Membrane Antigen as a Theranostic Target in Prostate Cancer: The Cornerstone Role of the Prostate Cancer Foundation
Andrea K. Miyahira and Howard R. Soule

Journal of Nuclear Medicine March 1, 2022, 63 (3) 331-338; DOI: https://doi.org/10.2967/jnumed.121.262997
You have access
Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen

Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
You have access
Mesothelin/CD3 Half-Life–Extended Bispecific T-Cell Engager Molecule Shows Specific Tumor Uptake and Distributes to Mesothelin and CD3-Expressing Tissues
Frans V. Suurs, Grit Lorenczewski, Julie M. Bailis, Sabine Stienen, Matthias Friedrich, Fei Lee, Bert van der Vegt, Elisabeth G.E. de Vries, Derk Jan A. de Groot and Marjolijn N. Lub-de Hooge

Journal of Nuclear Medicine December 1, 2021, 62 (12) 1797-1804; DOI: https://doi.org/10.2967/jnumed.120.259036
Open Access
Synthesis, preclinical evaluation, and a pilot clinical PET imaging study of ⁶⁸Ga-labeled FAPI dimer
Liang Zhao, Bo Niu, Jianyang Fang, Yizhen Pang, Siyang Li, Chengrong Xie, Long Sun, Xianzhong Zhang, Zhide Guo, Qin Lin and Haojun Chen

Journal of Nuclear Medicine September 23, 2021, jnumed.121.263016; DOI: https://doi.org/10.2967/jnumed.121.263016
You have access
Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
You have access
Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy
Vilma I.J. Jallinoja and Jacob L. Houghton

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1200-1206; DOI: https://doi.org/10.2967/jnumed.120.260687

Main menu

User menu

Search

PET imaging

Pages